Selective antihyperalgesic effect of [Ser1] histogranin on complete Freund's adjuvant-induced hyperalgesia in rats

Pain

Volumn 95, Issue 1-2, 2002, Pages 15-21

  Hama, Aldric ^a   Sagen, Jacqueline ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Adrenal medulla; Antinociception; Inflammatory pain; N methyl D aspartate glutamate receptor antagonist; Spinal cord

Indexed keywords

FREUND ADJUVANT; HISTOGRANIN[1 SERINE]; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; TREATMENT OUTCOME; WITHDRAWAL REFLEX;

ANALGESICS, NON-NARCOTIC; ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; FREUND'S ADJUVANT; HEAT; HYPERALGESIA; MALE; PAIN THRESHOLD; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TOUCH;

EID: 0036147446     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00368-2     Document Type: Article

References (43)

1. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat
2. Time-related roles of excitatory amino acid receptors during persistent noxious evoked responses of rat dorsal horn neurons
3. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal, and chemical nociceptive tests
4. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury
5. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions
6. 1]histogranin
7. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
8. Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats
9. Spinal antinociception mediated by a cocaine-sensitive dopaminergic supraspinal mechanism
10. The role of peripheral N-methyl-D-aspartate receptors in Freund's complete adjuvant induced mechanical hyperalgesia in rats
11. Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity
12. Histogranin, a modified histone H4 fragment endowed with N-methyl-D-aspartate antagonist and immunostimulatory activities
13. D2 dopamine receptor involvement in spinal dopamine-produced antinociception
14. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy
15. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy
16. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats
17. Low affinity use-dependent NMDA receptor antagonists show promise for clinical development
18. Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists - In vitro characterisation
19. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy
20. NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw
21. The effects of non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation
22. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats
23. An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat
24. 1]histogranin binding sites in rat brain
25. Non-opioid antinociceptive effects of supraspinal histogranin and related peptides: Possible involvement of central dopamine D(2) receptor
26. 1] histogranin
27. A natural peptide with NMDA inhibitory activity reduces tonic pain in the formalin model
28. Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity
29. Pre treatment with MK-801, a non-competitive NMDA antagonists, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation
30. Cooperative interaction among the various regulatory sites within the NMDA receptor-channel complex in modulating the evoked responses to noxious thermal stimuli of spinal dorsal horn neurons in the cat
31. Suppressive effects of ketamine on neuropathic pain
32. Neuropathic pain sensations are differentially sensitive to dextrorphan
33. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist
34. NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin
35. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats
36. Dorsal and ventral dopaminergic innervation of the spinal cord: Functional implications
37. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
38. Chronic catheterization of the spinal subarachnoid space
39. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat
40. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists
41. Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain
42. Pre-emptive intrathecal MK-801, a non-competitive N-methyl-D-aspartate receptor antagonist, inhibits the up-regulation of spinal dynorphin mRNA and hyperalgesia in a rat model of chronic inflammation